U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07441447) titled 'Evaluation of Muscle Strength and Muscle Mass in Patients With Inflammatory Bowel Disease' on Feb. 23.
Brief Summary: This prospective observational study aims to evaluate the validity of ultrasonographic muscle measurements in patients with inflammatory bowel disease (IBD). Sarcopenia is commonly assessed using computed tomography (CT)-based skeletal muscle area measurements at the L3 vertebral level, which are considered a gold standard method. However, CT is not always feasible due to radiation exposure and accessibility limitations.
In this study, muscle strength will be assessed using handgrip dynamometry, and muscle mass will...